These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16081030)

  • 21. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.
    van Venrooij WJ; Zendman AJ; Pruijn GJ
    Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
    Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
    Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New diagnostic and evaluative tests for rheumatoid arthritis].
    Hayashi N; Nishimura K; Morinobu A; Kumagai S
    Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
    Dubrous P; Gardet V; Hugard L
    Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2007; 36(2):97-100. PubMed ID: 17476614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New biomarkers for rheumatoid arthritis].
    Hayashi N; Nishimura K; Kumagai S
    Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
    Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
    J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
    Verpoort KN; Jol-van der Zijde CM; Papendrecht-van der Voort EA; Ioan-Facsinay A; Drijfhout JW; van Tol MJ; Breedveld FC; Huizinga TW; Toes RE
    Arthritis Rheum; 2006 Dec; 54(12):3799-808. PubMed ID: 17133560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.
    Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F
    Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    van Venrooij WJ; van de Putte LB
    Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.
    Vander Cruyssen B; Cantaert T; Nogueira L; Clavel C; De Rycke L; Dendoven A; Sebag M; Deforce D; Vincent C; Elewaut D; Serre G; De Keyser F
    Arthritis Res Ther; 2006; 8(4):R122. PubMed ID: 16859515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
    Niewold TB; Harrison MJ; Paget SA
    QJM; 2007 Apr; 100(4):193-201. PubMed ID: 17434910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical significance of cyclic citrullinated peptide antibodies: new data].
    Novikov AA; Aleksandrova EN; Nasonov EL
    Klin Med (Mosk); 2007; 85(8):4-9. PubMed ID: 17926481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
    Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
    J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
    Braun-Moscovici Y; Markovits D; Zinder O; Schapira D; Rozin A; Ehrenburg M; Dain L; Hoffer E; Nahir AM; Balbir-Gurman A
    J Rheumatol; 2006 Mar; 33(3):497-500. PubMed ID: 16511906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies.
    Vasishta A
    Am Clin Lab; 2002; 21(7):34-6. PubMed ID: 12380030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
    Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
    J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.